Facebook
Twitter
LinkedIn
Forward
The Role of Reinsurance and Stop-Loss Programs in Managing High-Investment Medications
Pricing: Free for Members and $30 for Non-Members
Course Description
The promise of cell and gene therapies as a means to cure rare conditions is exciting for health care providers and patients alike. It is well-known that these therapies may also come at a significant cost—hence the term “high-investment medications.”
While many innovative strategies have been discussed, more data and experience are needed before these models can be fully implemented. Some organizations have turned to reinsurance and stop-loss programs to help offset the risk posed by “high investment medications” and other types of catastrophic coverage needs.
This session will provide a deep dive into reinsurance and stop-loss coverage. How do these programs work? What are the common trends seen with this type of coverage? What organizations tend to use this type of coverage and why? Come join this session as experts delve into the practicality of reinsurance and stop-loss coverage.
Target Audience
Pharmacists who practice in managed care settings.
Learning Objectives
At the completion of this activity, participants should be able to:
- Define reinsurance and stop-loss coverage and how these programs are typically used.
- Explain current trends on how reinsurance and stop-loss coverage is being used with high-investment medications.
- Summarize the future role of reinsurance and stop-loss coverage with high-investment medications and other catastrophic claim
Faculty
Rick Lassow, FSA, MAAA
VP, Actuarial & Underwriting
Summit Re
Roseville, MN
Moderator
Soumya Vishwanath, PharmD
Senior Manager, Formulary Strategy
Magellan Rx Management
Boston, Massachusetts
Financial Relationship Disclosures
| Faculty/Reviewer/Planner | Reported Relevant Financial Relationships |
| Rick Lassow Faculty | Disclosed no relevant financial relationships. |
| Ani Khachatourian Reviewer | Disclosed no relevant financial relationships. |
| Ruby Singh Planner | Disclosed no relevant financial relationships. |
- If applicable, relevant financial relationships have been mitigated and documented.
- Content has undergone a peer review to ensure content validity.
Accreditation:
The Academy of Managed Care Pharmacy (AMCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
ACPE UAN:0233-0000-23-006-H99-P • Activity Type: Knowledge-Based
Contact Hours: 1.25
Release Date: March 22, 2023 • Expiration Date: December 31, 2024
Activity Fee: Free for Members and $30 for Non-Members
Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live activity presented at AMCP 2023. CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.
To receive credit for an online activity you must:
- Review the full content of the activity.
- Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
- Complete a specific activity evaluation.
Available Credit
- 1.25 ACPE
The Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. - 1.25 Certificate of Completion
Price
Required Hardware/software
System Requirements Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating websites. View the minimum technical and system requirements for continuing education online learning activities